Biomolecules & Therapeutics

  • 제22권3호
  • /
  • Pages.223-231
  • /
  • 2014
  • /
  • 1976-9148(pISSN)
  • /
  • 2005-4483(eISSN)
한국응용약물학회 (The Korean Society of Applied Pharmacology)
권호 표지
DOI QR코드

DOI QR Code

Cordycepin-Enriched WIB801C from Cordyceps militaris Inhibits Collagen-Induced [Ca2+]i Mobilization via cAMP-Dependent Phosphorylation of Inositol 1, 4, 5-Trisphosphate Receptor in Human Platelets

  • Lee, Dong-Ha (Department of Biomedical Laboratory Science, College of Biomedical Science and Engineering, Inje University) ;
  • Kim, Hyun-Hong (Department of Biomedical Laboratory Science, College of Biomedical Science and Engineering, Inje University) ;
  • Cho, Hyun-Jeong (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University) ;
  • Yu, Young-Bin (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University) ;
  • Kang, Hyo-Chan (Department of Medical Laboratory Science, Dong-Eui Institute of Technology) ;
  • Kim, Jong-Lae (Bioscience & Biotechnology Team, Central Research Center, Whanin Pharm. Co., Ltd.) ;
  • Lee, Jong-Jin (Bioscience & Biotechnology Team, Central Research Center, Whanin Pharm. Co., Ltd.) ;
  • Park, Hwa-Jin (Department of Biomedical Laboratory Science, College of Biomedical Science and Engineering, Inje University)
  • 투고 : 2014.02.26
  • 심사 : 2014.05.12
  • 발행 : 2014.05.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

In this study, we prepared cordycepin-enriched (CE)-WIB801C, a n-butanol extract of Cordyceps militaris-hypha, and investigated the effect of CE-WIB801C on collagen-induced human platelet aggregation. CE-WIB801C dose-dependently inhibited collagen-induced platelet aggregation, and its $IC_{50}$ value was $175{\mu}g/ml$. CE-WIB801C increased cAMP level more than cGMP level, but inhibited collagen-elevated $[CA^{2+}]_i$ mobilization and thromboxane $A_2$ ($TXA_2$) production. cAMP-dependent protein kinase (A-kinase) inhibitor Rp-8-Br-cAMPS increased the CE-WIB801C-downregulated $[CA^{2+}]_i$ level in a dose dependent manner, and strongly inhibited CE-WIB801C-induced inositol 1, 4, 5-trisphosphate receptor ($IP_3R$) phosphorylation. These results suggest that the inhibition of $[CA^{2+}]_i$ mobilization by CE-WIB801C is resulted from the cAMP/A-kinase-dependent phosphorylation of $IP_3R$. CE-WIB801C suppressed $TXA_2$ production, but did not inhibit the activities of cyclooxygenase-1 (COX-1) and $TXA_2$ synthase (TXAS). These results suggest that the inhibition of $TXA_2$ production by WIB801C is not resulted from the direct inhibition of COX-1 and TXAS. In this study, we demonstrate that CE-WIB801C with cAMP-dependent $CA^{2+}$-antagonistic antiplatelet effects may have preventive or therapeutic potential for platelet aggregation-mediated diseases, such as thrombosis, myocardial infarction, atherosclerosis, and ischemic cerebrovascular disease.

키워드

참고문헌

  1. Barragan, P., Bouvier, J. L., Roquebert, P. O., Macaluso, G., Commeau, P., Comet, B., Lafont, A., Camoin, L., Walter, U. and Eigenthaler, M. (2003) Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheter. Cardiovasc. Interv. 59, 295-302. https://doi.org/10.1002/ccd.10497
  2. Bell, R. L., Kennerly, D. A., Stanford, N. and Majerus, P. W. (1979) Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc. Natl. Acad. Sci. U.S.A. 76, 3238-3241. https://doi.org/10.1073/pnas.76.7.3238
  3. Butt, E., Abel, K., Krieger, M., Palm, D., Hoppe, V., Hoppe, J. and Walter, U. (1994) cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J. Biol. Chem. 269, 14509-14517.
  4. Cavallini, L., Coassin, M., Borean, A. and Alexandre, A. (1996) Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J. Biol. Chem. 271, 5545-5551. https://doi.org/10.1074/jbc.271.10.5545
  5. Cho, H. J., Cho, J. Y., Rhee, M. H. and Park, H. J. (2007) Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner. Eur. J. Pharmacol. 558, 43-51. https://doi.org/10.1016/j.ejphar.2006.11.073
  6. Cho, H. J., Kang, H. J., Kim, Y. J., Lee, D. H., Kwon, H. W., Kim, Y. Y. and Park, H. J. (2012) Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner. Blood Coagul. Fibrinolysis 23, 629-635. https://doi.org/10.1097/MBC.0b013e3283570846
  7. Cipollone, F., Patrignani, P., Greco, A., Panara, M. R., Padovano, R., Cuccurullo, F., Patrono, C., Rebuzzi, A. G., Liuzzo, G., Quaranta, G. and Maseri, A. (1997) Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 6, 1109-1116.
  8. Cunningham, K. G., Hutchinson, S. A., Manson, W. and Spring, F. S. (1951) Cordycepin: A metabolic product from cultures Cordyceps militaris Link. Part I. Isolation and characterization. J. Chem. Soc. 2, 2299-2300.
  9. Halbrugge, M. and Walter, U. (1989) Purification of a vasodilator-regulated phosphoprotein from human platelets. Eur. J. Biochem. 185, 41-50. https://doi.org/10.1111/j.1432-1033.1989.tb15079.x
  10. Halbrugge, M., Friedrich, C., Eigenthaler, M., Schanzenbacher, P. and Walter, U. (1990) Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J. Biol. Chem. 265, 3088-3093.
  11. Haslam, R. J., Davidson, M. M., Desjardins, J. V. (1978) Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem. J. 176, 83-95. https://doi.org/10.1042/bj1760083
  12. Jang, E. K., Azzam, J. E., Dickinson, N. T., Davidson, M. M. and Haslam, R. J. (2002) Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside. Br. J. Haematol. 117, 664-675. https://doi.org/10.1046/j.1365-2141.2002.03479.x
  13. Kaibuchi, K., Sano, K., Hoshijima, M., Takai, Y. and Nishizuka, Y. (1982) Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium 3, 323-335. https://doi.org/10.1016/0143-4160(82)90020-3
  14. Lee, D. H., Kim, H. H., Cho, H. J., Bae, J. S., Yu, Y. B. and Park, H. J. (2014) Antiplatelet effects of caffeic acid due to $Ca^{2+}$ mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation. J. Atheroscler. Thromb. 21, 24-37.
  15. Londos, C., Wolff, J. (1977) Two distinct adenosine-sensitive sites on adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 74, 5482-5486. https://doi.org/10.1073/pnas.74.12.5482
  16. Mauco, G., Fauvel, J., Chap, H., and Douste-Blazy, L., (1984) Studies on enzymes related to diacylglycerol production in activated platelets. II. Subcellular distribution, enzymatic properties and positional specificity of diacylglycerol- and monoacylglycerol-lipases. Biochim. Biophys. Acta 796, 169-177. https://doi.org/10.1016/0005-2760(84)90345-X
  17. Menshikov, Myu., Ivanova, K., Schaefer, M., Drummer, C. and Gerzer, R. (1993) Influence of the cGMP analog 8-PCPT-cGMP on agonistinduced increases in cytosolic ionized $Ca^{2+}$ and on aggregation of human platelets. Eur. J. Pharmacol. 245, 281-284. https://doi.org/10.1016/0922-4106(93)90108-L
  18. Moriyama, T., Wada, K., Oki, M., Matsuura, T. and Kitom, M. (1994) The mechanism of arachidonic acid release in collagen-activated human platelets. Biosci. Biotechnol. Biochem. 58, 93-98. https://doi.org/10.1271/bbb.58.93
  19. Ng, T. B. and Wang, H. X. (2005) Pharmacological actions of Cordyceps, a prized folk medicine. J. Pharm. Pharmacol. 57, 1509-1519. https://doi.org/10.1211/jpp.57.12.0001
  20. Nishikawa, M., Tanaka, T. and Hidaka, H. (1980) $Ca^{2+}$-calmodulin dependent phosphorylation and platelet secretion. Nature 287, 863-865. https://doi.org/10.1038/287863a0
  21. Ok, W. J., Cho, H. J., Kim, H. H., Lee, D. H., Kang, H. Y., Kwon, H. W., Rhee, M. H., Kim, M. and Park, H. J. (2012) Epigallocatechin-3- gallate has an anti-platelet effect in a cyclic AMP-dependent man ner. J. Atheroscler. Thromb. 19, 337-348. https://doi.org/10.5551/jat.10363
  22. Quinton, T. M. and Dean, W. L. (1992) Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits $Ca^{2+}$ release from platelet membranes. Biochem. Biophys. Res. Commun. 184, 893-899. https://doi.org/10.1016/0006-291X(92)90675-B
  23. Patrono, C. (1994) Aspirin as an antiplatelet drug. N. Engl. J. Med. 330, 1287-1294. https://doi.org/10.1056/NEJM199405053301808
  24. Schaeffer, J. and Blaustein, M. P. (1989) Platelet free calcium concentrations measured with fura-2 are influenced by the transmembrane sodium gradient. Cell Calcium 10, 101-113. https://doi.org/10.1016/0143-4160(89)90050-X
  25. Schwartz, S. M., Heinmark, R. L. and Majesky, M. W. (1990) Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70, 1177-1209.
  26. Schwarz, U. R., Walter, U. and Eigenthaler, M. (2001) Taming platelets with cyclic nucleotides. Biochem. Pharmacol. 62, 1153-1161. https://doi.org/10.1016/S0006-2952(01)00760-2
  27. Walter, U. and Gambaryan, S. (2009) cGMP and cGMP-dependent protein kinase in platelets and blood cells. Handb. Exp. Pharmacol. 191, 533-548. https://doi.org/10.1007/978-3-540-68964-5_23
  28. Wonerow, P., Obergfell, A., Wilde, J. I., Bobe, R., Asazuma, N., Brdicka, T., Leo, A., Schraven, B., Horejsi, V., Shattil, S. J. and Watson, S. P. (2002) Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets. Biochem. J. 364, 755-765. https://doi.org/10.1042/bj20020128
  29. Yue, G. G., Lau, C. B., Fung, K. P., Leung, P. C. and Ko, W. H. (2008) Effects of Cordyceps sinensis, Cordyceps militaris and their isolated compounds on ion transport in Calu-3 human airway epithelial cells. J. Ethnopharmacol. 117, 92-101. https://doi.org/10.1016/j.jep.2008.01.030

피인용 문헌

  1. Pro-Apoptotic Activity of 4-Isopropyl-2-(1-Phenylethyl) Aniline Isolated from Cordyceps bassiana vol.23, pp.4, 2015, https://doi.org/10.4062/biomolther.2015.021
  2. Anticancer Efficacy of Cordyceps militaris Ethanol Extract in a Xenografted Leukemia Model vol.2017, 2017, https://doi.org/10.1155/2017/8474703
  3. Post-ischemic treatment of WIB801C, standardized Cordyceps extract, reduces cerebral ischemic injury via inhibition of inflammatory cell migration vol.186, 2016, https://doi.org/10.1016/j.jep.2016.03.052
  4. Effect of Cordycepin-Enriched WIB801C from Cordyceps militaris Suppressing Fibrinogen Binding to Glycoprotein IIb/IIIa vol.23, pp.1, 2015, https://doi.org/10.4062/biomolther.2014.086
  5. Antiproliferative and Apoptosis-Inducing Activities of 4-Isopropyl-2,6-bis(1-phenylethyl)phenol Isolated from Butanol Fraction ofCordyceps bassiana vol.2015, 2015, https://doi.org/10.1155/2015/739874
  6. Actions of water extract from Cordyceps militaris in hyperuricemic mice induced by potassium oxonate combined with hypoxanthine vol.194, 2016, https://doi.org/10.1016/j.jep.2016.10.001
  7. Antiplatelet Effects of Cordycepin-Enriched WIB-801CE from Cordyceps militaris: Involvement of Thromboxane A2,Serotonin, Cyclooxygenase-1, Thromboxane A2 Synthase,Cytosolic Phospholipase A2 vol.22, pp.4, 2016, https://doi.org/10.15616/BSL.2016.22.4.127
  8. Cordycepin-enriched WIB-801C from Cordyceps militaris improves functional recovery by attenuating blood-spinal cord barrier disruption after spinal cord injury vol.203, 2017, https://doi.org/10.1016/j.jep.2017.03.047
  9. Green synthesis of gold nanoparticles using a Cordyceps militaris extract and their antiproliferative effect in liver cancer cells (HepG2) vol.47, pp.1, 2014, https://doi.org/10.1080/21691401.2019.1629952
  10. FDY003의 항산화활성 및 표준화 연구 vol.40, pp.6, 2019, https://doi.org/10.22246/jikm.2019.40.6.1112
  11. Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety vol.2021, pp.None, 2014, https://doi.org/10.1155/2021/9956248